About Boehringer Ingelheim

The pharmaceutical company Boehringer Ingelheim was founded in 1885 by Albert Boehringer (1861-1939) in Ingelheim am Rhein. Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing.

A leader in respiratory disease

Boehringer Ingelheim has over 90 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area, having launched several treatments in a range of respiratory conditions including asthma, chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF) and lung cancer. Our focus is on improving the quality of life of patients suffering from debilitating respiratory diseases and enabling them to maintain a more independent life.

Respimat®

The unique mist that makes its way deep into patients’ lungs. Visit the Respimat®site to learn more.

VISIT NOW

AsthmaXchange

AsthmaXchange is an online educational resource for healthcare professionals, providing interactive e-learning resources and practical tools on the diagnosis, treatment and management of asthma.

VISIT NOW

SPIRIVA® COPD

Visit the global SPIRIVA® (tiotropium) COPD site for healthcare professionals.

VISIT NOW

Think Act Breathe

Think, Act, Breathe is for patients and healthcare professionals. It aims to help identify the approximately 1 in 2 people with asthma who still experience symptoms despite taking current treatments and are at increased risk of potentially life threatening asthma exacerbations.

VISIT NOW

Boehringer Ingelheim

Visit our corporate website and discover what we are doing in the field of respiratory medicine and other specialties.

VISIT NOW